Abstract
The compaction of DNA into chromatin provides an additional level of gene regulation in eukaryotes that may not be available to prokaryotes. When packaged as chromatin, most promoters are transcriptionally repressed, and transcription factors have reduced access to their binding sites. The glucocorticoid receptor (GR) is a ligand-activated transcription factor that regulates the activity of genes involved in many physiological processes. To regulate eukaryotic genes, the GR binds to target sites within promoter regions of genes assembled as chromatin. This interaction alters the nucleosomal architecture to allow binding of other transcription factors, and formation of the preinitiation complex. The mouse mammary tumor virus (MMTV) promoter has been used extensively as a model to explore the processes by which the GR remodels chromatin and activates transcription. Significant progress has been made in our understanding of the mechanisms used by the GR to modify chromatin structure, and the limits placed on the GR by post-translational modifications of histones. We will describe recent developments in the processes used by the GR to activate transcription in vivo via chromatin remodeling complexes, histone H1 phosphorylation, and recruitment of diverse coactivators.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Archer TK, Cordingley MG, Marsaud V, Richard-Foy H, Hager GL . 1989 The Steriod/Thyroid Hormone Receptor Family and Gene Regulation Carlstedt-Duke J, Eriksson H and Gustafsson JA (eds). Birkhauser Verlag: Basel pp. 221–238
Archer TK, Deroo BJ, Fryer CJ . 1997 Trends Endocrin. Metab. 8: 384–390
Archer TK, LeFebvre P, Wolford RG, Hager GL . 1992 Science 255: 1573–1576
Archer TK, Zaniewski E, Moyer ML, Nordeen SK . 1994 Mol. Endocrinol 8: 1154–1162
Armstrong JA, Bieker JJ, Emerson BM . 1998 Cell 95: 93–104
Bartsch J, Truss M, Bode J, Beato M . 1996 Proc. Natl. Acad. Sci. USA 93: 10741–10746
Bouvet P, Dimitrov S, Wolffe AP . 1994 Genes Dev. 8: 1147–1159
Bresnick EH, Bustin M, Marsaud V, Richard-Foy H, Hager GL . 1992 Nucleic. Acids Res. 20: 273–278
Bresnick EH, John S, Berard DS, LeFebvre P, Hager GL . 1990 Proc. Natl. Acad. Sci. USA 87: 3977–3981
Cheung P, Allis CD, Sassone-Corsi P . 2000 Cell 103: 263–271
Collingwood TN, Urnov FD, Wolffe AP . 1999 J. Mol. Endocrinol. 23: 255–275
Crane-Robinson C . 1999 Bioessays 21: 367–371
Dou Y, Mizzen CA, Abrams M, Allis CD, Gorovsky MA . 1999 Mol. Cell 4: 641–647
Eisen JA, Sweder KS, Hanawalt PC . 1995 Nucleic. Acids Res. 23: 2715–2723
Fletcher TM, Hansen JC . 1996 Crit. Rev. Eukaryot. Gene Expr. 6: 149–188
Fletcher TM, Ryu BW, Baumann CT, Warren BS, Fragoso G, John S, Hager GL . 2000 Mol. Cell. Biol. 20: 6466–6475
Fryer CJ, Archer TK . 1998 Nature 393: 88–91
Fryer CJ, Kinyamu HK, Rogatsky I, Garabedian MJ, Archer, TK . 2000 J. Biol. Chem. 275: 17771–17777
Fryer CJ, Nordeen SK, Archer TK . 1998 J. Biol. Chem. 273: 1175–1183
Gross DS, Garrard WT . 1988 Annu. Rev. Biochem. 57: 159–197
Hager GL, Archer TK . 1991 Nuclear hormone receptors Parker M. (ed) Academic Press: London UK pp. 217–234
Havas K, Flaus A, Phelan M, Kingston R, Wade PA, Lilley DMJ, Owen-Hughes T . 2000 Cell 103: 1133–1142
Hill DA, Imbalzano AN . 2000 Biochemistry 39: 11649–11656
Kadam S, McAlpine GS, Phelan ML, Kingston RE, Jones KA, Emerson BM . 2000 Genes Dev. 14: 2441–2451
Karin M . 1998 Cell 93: 487–490
Kinyamu HK, Fryer CJ, Horwitz KB, Archer TK . 2000 J. Biol. Chem. 275: 20061–20068
Lee HL, Archer TK . 1994 Mol. Cell. Biol. 14: 32–41
Lee HL, Archer TK . 1998 EMBO J. 17: 1454–1466
Lever MA, Th'ng JPH, Sun X, Hendzel MJ . 2000 Nature 408: 873–876
Logie C, Peterson CL . 1997 EMBO J. 16: 6772–6782
Lorch Y, Zhang M, Kornberg RD . 1999 Cell 96: 389–392
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM . 1995 Cell 83: 835–839
McNally JG, Muller WG, Walker D, Wolford R, Hager GL . 2000 Science 287: 1262–1265
Misteli T, Gunjan A, Hock R, Bustin M, Brown DT . 2000 Nature 408: 877–881
Mizzen CA, Dou Y, Liu Y, Cook RG, Gorovsky MA, Allis CD . 1999 J. Biol. Chem. 274: 14533–14536
Muchardt C, Yaniv M . 1993 EMBO J. 12: 4279–4290
Mymryk JS, Archer TK . 1995 Genes Dev. 9: 1366–1376
Mymryk JS, Berard D, Hager GL, Archer TK . 1995 Mol. Cell. Biol. 15: 26–34
Nie Z, Xue Y, Yang D, Zhou S, Deroo BJ, Archer TK, Wang W . 2000 Mol. Cell. Biol. 20: 8879–8888
Orphanides G, Reinberg D . 2000 Nature 407: 471–475
Ostlund Farrants AK, Blomquist P, Kwon H, Wrange O . 1997 Mol. Cell. Biol. 17: 895–905
Owen-Hughes T, Utley RT, Cote J, Peterson CL, Workman JL . 1996 Science 273: 513–516
Phelan ML, Sif S, Narlikar GJ, Kingston RE . 1999 Mol. Cell. 3: 247–253
Robyr D, Wolffe AP, Wahli W . 2000 Mol. Endocrinol. 14: 329–347
Schnitzler G, Sif S, Kingston RE . 1998 Cell 94: 17–27
Shen X, Gorovsky MA . 1996 Cell 86: 475–483
Steinback OC, Wolffe AP, Rupp RA . 1997 Nature 389: 395–399
Struhl K . 1998 Genes Dev. 12: 599–606
Sudarsanam P, Winston F . 2000 Trends Genet. 16: 345–351
Vignali M, Hassan AH, Neely KE, Workman JL . 2000 Mol. Cell. Biol. 20: 1899–1910
Wallberg AE, Neely KE, Hassan AH, Gustafsson JA, Workman JL, Wright AP . 2000 Mol. Cell. Biol. 20: 2004–2013
Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, Workman JL, Crabtree GR . 1996a EMBO J. 15: 5370–5382
Wang W, Zue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR . 1996b Genes Dev. 10: 2117–2130
Weinberger C, Hollenberg SM, Ong ES, Harmon JM, Brower ST, Cidlowski J, Thompson EB, Rosenfeld MG, Evans RM . 1985 Science 228: 740–742
Whitehouse I, Flaus A, Cairns BR, White MF, Workman JL, Owen-Hughes T . 1999 Nature 400: 784–787
Windahl SH, Treuter E, Ford J, Zilliacus J. Gustafsson JA, McEwan IJ . 1999 J. Steroid Biochem. Mol. Biol. 71: 93–102
Wolffe AP, Hayes JJ . 1999 Nucleic. Acids Res. 27: 711–720
Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, Ghaffari S, Iliev D, Penn B, Woodland AM, Smith R, Salada G, Carillo A, Laity K, Gupte J, Swedlund B, Tavtigian SV, Teng DH, Lees E . 2000 Cancer Res. 60: 6171–6177
Yamamoto KR . 1985 Annu. Rev. Genet. 19: 209–252
Zhang L, Spratt SK, Liu Q, Johnstone B, Qi H, Raschke EE, Jamieson AC, Rebar EJ, Wolffe AP, Case CC . 2000 J. Biol. Chem. 275: 33850–33860
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Deroo, B., Archer, T. Glucocorticoid receptor-mediated chromatin remodeling in vivo. Oncogene 20, 3039–3046 (2001). https://doi.org/10.1038/sj.onc.1204328
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204328
Keywords
This article is cited by
-
Sperm chromatin accessibility’s involvement in the intergenerational effects of stress hormone receptor activation
Translational Psychiatry (2023)
-
Translation of MMTV Gag requires nuclear events involving splicing motifs in addition to the viral Rem protein and RmRE
Retrovirology (2012)
-
Glucocorticoid receptor and breast cancer
Breast Cancer Research and Treatment (2011)
-
Metabolic correlations of glucocorticoids and polyamines in inflammation and apoptosis
Amino Acids (2010)
-
Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone
Cell Research (2004)